John Couling Sells 7,273 Shares of Dolby Laboratories (NYSE:DLB) Stock

Dolby Laboratories (NYSE:DLB) SVP John Couling sold 7,273 shares of the firm’s stock in a transaction that occurred on Thursday, December 11th. The shares were sold at an average price of $68.75, for a total transaction of $500,018.75. Following the completion of the sale, the senior vice president owned 108,065 shares of the company’s stock, valued at approximately $7,429,468.75. This trade represents a 6.31% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Dolby Laboratories Trading Down 1.4%

Shares of DLB stock traded down $0.96 during trading hours on Monday, reaching $66.58. 541,392 shares of the company’s stock were exchanged, compared to its average volume of 469,418. Dolby Laboratories has a fifty-two week low of $64.02 and a fifty-two week high of $89.66. The stock’s 50 day moving average is $67.15 and its 200-day moving average is $71.39. The company has a market cap of $6.36 billion, a price-to-earnings ratio of 25.31 and a beta of 0.89.

Dolby Laboratories (NYSE:DLB) last posted its quarterly earnings data on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share for the quarter, topping analysts’ consensus estimates of $0.70 by $0.29. Dolby Laboratories had a return on equity of 11.99% and a net margin of 18.90%.The firm had revenue of $307.02 million during the quarter, compared to analysts’ expectations of $305.76 million. During the same quarter last year, the firm earned $0.61 EPS. The business’s quarterly revenue was up .7% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. Equities analysts anticipate that Dolby Laboratories will post 2.94 EPS for the current year.

Dolby Laboratories Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, December 10th. Stockholders of record on Tuesday, December 2nd were issued a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a dividend yield of 2.2%. This is an increase from Dolby Laboratories’s previous quarterly dividend of $0.33. The ex-dividend date was Tuesday, December 2nd. Dolby Laboratories’s dividend payout ratio is currently 54.75%.

Institutional Trading of Dolby Laboratories

Several large investors have recently made changes to their positions in DLB. Boothbay Fund Management LLC boosted its stake in shares of Dolby Laboratories by 4.1% during the 2nd quarter. Boothbay Fund Management LLC now owns 4,020 shares of the electronics maker’s stock worth $299,000 after acquiring an additional 157 shares in the last quarter. MAI Capital Management increased its stake in shares of Dolby Laboratories by 87.1% in the 1st quarter. MAI Capital Management now owns 348 shares of the electronics maker’s stock valued at $28,000 after purchasing an additional 162 shares in the last quarter. Mitchell & Pahl Private Wealth LLC raised its holdings in Dolby Laboratories by 1.1% in the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 15,733 shares of the electronics maker’s stock worth $1,139,000 after purchasing an additional 170 shares during the period. Equitable Trust Co. raised its holdings in Dolby Laboratories by 3.3% in the 2nd quarter. Equitable Trust Co. now owns 5,567 shares of the electronics maker’s stock worth $413,000 after purchasing an additional 177 shares during the period. Finally, Steward Partners Investment Advisory LLC boosted its position in Dolby Laboratories by 13.9% during the second quarter. Steward Partners Investment Advisory LLC now owns 1,587 shares of the electronics maker’s stock worth $118,000 after purchasing an additional 194 shares in the last quarter. 58.56% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts recently commented on DLB shares. Barrington Research decreased their price objective on shares of Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating for the company in a research report on Wednesday, November 19th. Wall Street Zen lowered shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, November 22nd. Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Monday, December 8th. Baird R W raised shares of Dolby Laboratories to a “hold” rating in a report on Friday, September 5th. Finally, Robert W. Baird started coverage on Dolby Laboratories in a research report on Friday, September 5th. They issued a “neutral” rating and a $74.00 target price on the stock. Three investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $92.00.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.